DENTSPLY SIRONA Inc (XRAY) Stake Decreased by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. reduced its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 15.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 12,653 shares of the medical instruments supplier’s stock after selling 2,363 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in DENTSPLY SIRONA were worth $478,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Continental Advisors LLC lifted its holdings in shares of DENTSPLY SIRONA by 60.6% during the 2nd quarter. Continental Advisors LLC now owns 92,800 shares of the medical instruments supplier’s stock worth $4,062,000 after acquiring an additional 35,000 shares during the period. Bank of Montreal Can lifted its holdings in shares of DENTSPLY SIRONA by 65.8% during the 3rd quarter. Bank of Montreal Can now owns 388,396 shares of the medical instruments supplier’s stock worth $14,658,000 after acquiring an additional 154,125 shares during the period. Nuance Investments LLC lifted its holdings in shares of DENTSPLY SIRONA by 134.6% during the 2nd quarter. Nuance Investments LLC now owns 2,174,311 shares of the medical instruments supplier’s stock worth $95,170,000 after acquiring an additional 1,247,670 shares during the period. Strs Ohio lifted its holdings in shares of DENTSPLY SIRONA by 28.4% during the 2nd quarter. Strs Ohio now owns 386,886 shares of the medical instruments supplier’s stock worth $16,934,000 after acquiring an additional 85,558 shares during the period. Finally, Qube Research & Technologies Ltd purchased a new position in shares of DENTSPLY SIRONA during the 2nd quarter worth about $134,000. Institutional investors and hedge funds own 97.90% of the company’s stock.

Several research firms recently commented on XRAY. Zacks Investment Research lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Monday, August 6th. Robert W. Baird lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and cut their price target for the company from $56.00 to $38.00 in a report on Tuesday, August 7th. BidaskClub upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Tuesday, July 31st. Barrington Research lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, August 9th. Finally, HC Wainwright set a $40.00 price target on shares of DENTSPLY SIRONA and gave the company a “hold” rating in a report on Friday, August 31st. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $51.50.

NASDAQ XRAY opened at $36.51 on Thursday. DENTSPLY SIRONA Inc has a one year low of $33.93 and a one year high of $68.98. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.10 and a current ratio of 1.69. The company has a market capitalization of $7.90 billion, a P/E ratio of 13.73, a price-to-earnings-growth ratio of 2.06 and a beta of 1.15.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Tuesday, August 7th. The medical instruments supplier reported $0.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.59 by $0.01. The firm had revenue of $1.04 billion for the quarter, compared to analyst estimates of $1.03 billion. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. During the same quarter last year, the firm posted $0.65 earnings per share. Equities research analysts predict that DENTSPLY SIRONA Inc will post 2.07 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “DENTSPLY SIRONA Inc (XRAY) Stake Decreased by Robeco Institutional Asset Management B.V.” was originally posted by WKRB News and is the sole property of of WKRB News. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.wkrb13.com/2018/11/08/dentsply-sirona-inc-xray-stake-decreased-by-robeco-institutional-asset-management-b-v.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Further Reading: Bear Market

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply